Green Thumb Industries (GTII) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Jun, 2026Opening remarks and agenda
Meeting called to order at 2:00 P.M. Central Time, with board, management, and auditors present.
Agenda and rules for orderly conduct were outlined, with instructions for shareholder participation and voting.
Quorum confirmed, and legal notice of meeting and proxy materials duly mailed and certified.
Board and executive committee updates
Number of directors set at seven, with all nominees properly nominated and elected.
Directors elected to serve until successors are appointed or as per corporate articles.
Shareholder proposals
Advisory vote on executive compensation presented and approved.
Appointment of Baker Tilly US, LLP as auditors for the current year, with board authorized to set terms.
Amendment to super-voting share conversion threshold from 50% to 25% approved.
Latest events from Green Thumb Industries
- Cannabis market growth and brand leadership drive strong financial results and national expansion.GTII
Investor presentation16 Jun 2026 - Cannabis market growth and brand leadership drive robust revenue and EBITDA performance.GTII
Investor presentation18 May 2026 - Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 202613 May 2026 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 202523 Apr 2026 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 202423 Apr 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 202525 Feb 2026 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 20253 Feb 2026 - Q2 revenue up 11% to $280M, net income $21M, adjusted EBITDA $94M; strong retail growth.GTII
Q2 20242 Feb 2026 - Record revenue, EBITDA, and cash flow drive growth amid pricing and regulatory challenges.GTII
Q4 202423 Dec 2025